HOUSTON, December 7, 2023 – FibroBiologics, Inc., a clinical-stage biotechnology company focused on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that it will hold an Investor Day on December 14, 2023, at 10 a.m. EST. A live webcast will be accessible here as well as […] The post FibroBiologics to Host Investor Day appeared first on FibroBiologics.
